These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8082666)

  • 1. Parameters influencing SPET regional brain uptake of technetium-99m hexamethylpropylene amine oxine measured by calibrated point sources as an external standard.
    Dierckx RA; Dobbeleir A; Maes M; Pickut BA; Vervaet A; De Deyn PP
    Eur J Nucl Med; 1994 Jun; 21(6):514-20. PubMed ID: 8082666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard: phantom and human studies.
    Dobbeleir A; Dierckx R
    Eur J Nucl Med; 1993 Aug; 20(8):684-9. PubMed ID: 8404955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
    Matsuda H; Tsuji S; Shuke N; Sumiya H; Tonami N; Hisada K
    Eur J Nucl Med; 1993 May; 20(5):391-401. PubMed ID: 8519258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type.
    Pickut BA; Dierckx RA; Dobbeleir A; Audenaert K; Van Laere K; Vervaet A; De Deyn PP
    Psychiatry Res; 1999 Apr; 90(2):103-12. PubMed ID: 10482382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Eur J Nucl Med; 1996 Jun; 23(6):683-9. PubMed ID: 8662103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes.
    Keymeulen B; de Metz K; Cluydts R; Bossuyt A; Somers G
    Eur J Nucl Med; 1996 Feb; 23(2):163-8. PubMed ID: 8925851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increment of brain temporal perfusion during auditory stimulation. Preliminary study with technetium-99m HMPAO SPET.
    Le Scao Y; Baulieu JL; Robier A; Pourcelot L; Beutter P
    Eur J Nucl Med; 1991; 18(12):981-3. PubMed ID: 1778211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain single-photon emission tomography with technetium-99m hexamethylpropylene amine oxime in adolescents with initial-stage schizophrenia.
    Batista JF; Galiano MC; Torres LA; Hernández MC; Sosa F; Perera A; Pérez M
    Eur J Nucl Med; 1995 Nov; 22(11):1274-7. PubMed ID: 8575476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of intravenously administered lidocaine on cerebral blood flow in a baboon model standardized under controlled general anaesthesia using single-photon emission tomography and technetium-99m hexamethylpropylene amine oxime.
    Dormehl IC; Lipp MD; Hugo N; Daublaender M; Picard JA
    Eur J Nucl Med; 1993 Nov; 20(11):1095-8. PubMed ID: 8287877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m HMPAO SPET in acute supratentorial ischaemic infarction, expressing deficits as millilitre of zero perfusion.
    Dierckx RA; Dobbeleir A; Pickut BA; Timmermans L; Dierckx I; Vervaet A; Vandevivere J; Deberdt W; De Deyn PP
    Eur J Nucl Med; 1995 May; 22(5):427-33. PubMed ID: 7641751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of technetium 99m cyclobutylpropylene amine oxime as a potential brain perfusion imaging agent for SPET.
    Bacciottini L; Lunghi F; Pupi A; Bonino C; Formiconi AR; De Cristofaro MT; Petti AR; Meldolesi U
    Eur J Nucl Med; 1990; 17(5):242-7. PubMed ID: 2083559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aging on the cerebral distribution of technetium-99m hexamethylpropylene amine oxime in healthy humans.
    Mozley PD; Sadek AM; Alavi A; Gur RC; Muenz LR; Bunow BJ; Kim HJ; Stecker MH; Jolles P; Newberg A
    Eur J Nucl Med; 1997 Jul; 24(7):754-61. PubMed ID: 9211761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.
    Grünwald F; Schomburg A; Badali A; Ruhlmann J; Pavics L; Biersack HJ
    Eur J Nucl Med; 1995 Sep; 22(9):1073-7. PubMed ID: 7588946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor stimulation response by technetium-99m hexamethylpropylene amine oxime split-dose method and single photon emission tomography.
    Pantano P; Di Piero V; Ricci M; Fieschi C; Bozzao L; Lenzi GL
    Eur J Nucl Med; 1992; 19(11):939-45. PubMed ID: 1425780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is image subtraction necessary in the clinical interpretation of single-day split-dose stress cerebral perfusion single-photon emission tomography using technetium-99m compounds?
    Wong CO; MacIntyre WJ; Chen EQ; Saha GB; Chyatte D; Go RT
    Eur J Nucl Med; 1996 Oct; 23(10):1309-14. PubMed ID: 8781134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of technetium-99m hexamethylpropylene amine oxime single-photon emission tomography to neurologic prognosis in patients undergoing urgent carotid surgery.
    Shvera IY; Cherniavsky AM; Ussov WY; Plotnikov MP; Sokolov AA; Shipulin VM; Chernov VI
    Eur J Nucl Med; 1995 Feb; 22(2):132-8. PubMed ID: 7758500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
    Hellman RS; Tikofsky RS; Van Heertum R; Coade G; Carretta R; Hoffmann RG
    Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A quantitative approach to the rCBF response to acetazolamide using 99mTc-HMPAO and graphical analysis].
    Terada H; Watanabe N; Gomi T; Murakami S; Nagamoto M; Kuwajima A; Hiramatsu Y; Iwabuchi S; Ushikubo Y; Samejima H
    Kaku Igaku; 1994 Apr; 31(4):367-71. PubMed ID: 8196233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.